WCH-016

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameWCH-016
Drug Alias NameWCH-016
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAMP-activated protein kinases activators
TargetsAMP-activated protein kinases
Therapy Area/IndicationsLipid Metabolism DisordersDiabetes Mellitus, Type 2Nutritional and Metabolic Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesSichuan University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSichuan UniversityGuangdong Zhongsheng Pharmaceutical Co LtdSouth China Center For Innovative Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsLipid Metabolism DisordersDiabetes Mellitus, Type 2Nutritional and Metabolic Diseases +[4] 

Other Information

ATC CodeN/A
Related LinksN/A